KALA BIO, Inc.

KALA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001479419

SEC filings (opens in a new tab)

No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding KALA BIO, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of KALA: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Q2 2026	Change
Holders	30	15	−15
Shares	1.70M	701.2K	−999.7K (−58.8%)
Value	$294.0K	$1.21M	+$919.1K (+312.6%)

New holders (4)

Institutions that held KALA BIO, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to KALA in Q2 2026
Institution	Shares	Value	% of portfolio
Qube Research & Technologies Ltd	11,073	$19.2K	0.00%
Tower Research Capital LLC (TRC)	616	$1.07K	0.00%
Barclays PLC	608	$1.05K	0.00%
Caitong International Asset Management Co., Ltd	10	$17	0.00%

Sold out (19)

Institutions that held KALA BIO, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of KALA in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Renaissance Technologies LLC	417,517	$72.3K
Citadel Advisors LLC	281,650	$48.8K
Virtu Financial LLC	152,197	$26.0K
ADAR1 Capital Management, LLC	141,480	$24.5K
Gsa Capital Partners LLP	84,470	$15.0K
Jane Street Group, LLC	36,000	$6.23K
JPMorgan Chase & Co	30,017	$5.13K
Grant Private Wealth Management Inc	20,000	$3.46K
Greenwich Wealth Management LLC	18,393	$3.00K
LPL Financial LLC	17,229	$2.98K
StoneX Group Inc.	12,984	$2.25K
Vanguard Global Advisers, LLC	832	$144
MAI Capital Management	300	$52
Cheviot Value Management, LLC	153	$26
Steward Partners Investment Advisory, LLC	120	$21
Legacy Wealth Managment, LLC	25	$5
SBI Securities Co., Ltd.	8	$1
Parallel Advisors, LLC	1	$0
Covestor Ltd	1,264	$0